ANTM News and Press, Anthem Inc. From 12/18/20

Jeremy Grantham’s 13F portfolio value increased from $13.47B to $14.05B this quarter. GMO Capital increased Coca-Cola and Lam Research while decreasing Apple, Alibaba Group Holdings, and Honeywell International. The largest three individual stock positions are Microsoft Cor...

Anthem (ANTM) announces that Dr. Shantanu Agrawal has been named Chief Health Officer, effective January 25, 2020. Dr. Agrawal will oversee Anthem’s enterprise health strategy, to include medical policy and clinical quality, as well as the company’s indu...

Anthem, Inc. (NYSE: ANTM) announced today Dr. Shantanu Agrawal has been named Chief Health Officer, effective January 25, 2020. Dr. Agrawal will oversee Anthem’s enterprise health strategy, to include medical policy and clinical quality, as well as the company’s industry-l...

Halvorsen's 13F portfolio value increased from $23.14B to $27.68B. The number of positions increased 71 to 86. Viking Global increased Microsoft, Mecadolibre, and CME Group while reducing Amazon.com and dropping Uber Technologies & JD.com. The top three positions are Microsoft...

Some health insurance investors are concerned about the growing political pressure for a government-based health insurer for all. The American public wants a government option in addition to, and not instead of, private insurance options. Anthem has a very large exposure to existi...

Actinium Highlights Clinical Data to be Presented at the Upcoming 62nd American Society of Hematology Annual Meeting NEW YORK , Dec. 3, 2020 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) ("Actinium") today highlighted that four abstracts detail...

The COVID-19 pandemic has altered the healthcare landscape and boosted the adoption of telehealth like never before. Rising cases of chronic diseases, an ageing population, and an advancement of technology have been driving the growth of digital healthcare. Stocks such as Anthem (ANTM), Telad...

Like every week on my TEV blog, I want to show you some stocks that will go ex-dividend in the next few days. I'll also review a few companies currently in the focus of investors or that have an attractive fundamental valuation. We even have several companies that pay a special di...

A weekly summary of dividend activity for Dividend Champions and Contenders. Companies which changed their dividends. Companies with upcoming ex-dividend dates. Companies with upcoming pay dates. For further details see: Dividend Champion And Contender Highlights: We...

Strong free cash flow, secular tailwinds, and low valuations make Cigna financially attractive. Returns in about 1 - 1.5 years are expected in the range of 40-50% with subsequent long-term compounding in line with historic 12-14%. Leverage will be reduced before the year-end and i...